Cargando…

Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing

Among 3302 persons tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by BinaxNOW(TM) and reverse transcription polymerase chain reaction (RT-PCR) in a community setting, rapid assay sensitivity was 100%/98.5%/89% using RT-PCR cycle thresholds of 30, 35, and no threshold. The sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilarowski, Genay, Marquez, Carina, Rubio, Luis, Peng, James, Martinez, Jackie, Black, Douglas, Chamie, Gabriel, Jones, Diane, Jacobo, Jon, Tulier-Laiwa, Valerie, Rojas, Susana, Rojas, Susy, Cox, Chesa, Nakamura, Robert, Petersen, Maya, DeRisi, Joseph, Havlir, Diane V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799223/
https://www.ncbi.nlm.nih.gov/pubmed/33367619
http://dx.doi.org/10.1093/cid/ciaa1890
_version_ 1783635110214500352
author Pilarowski, Genay
Marquez, Carina
Rubio, Luis
Peng, James
Martinez, Jackie
Black, Douglas
Chamie, Gabriel
Jones, Diane
Jacobo, Jon
Tulier-Laiwa, Valerie
Rojas, Susana
Rojas, Susy
Cox, Chesa
Nakamura, Robert
Petersen, Maya
DeRisi, Joseph
Havlir, Diane V
author_facet Pilarowski, Genay
Marquez, Carina
Rubio, Luis
Peng, James
Martinez, Jackie
Black, Douglas
Chamie, Gabriel
Jones, Diane
Jacobo, Jon
Tulier-Laiwa, Valerie
Rojas, Susana
Rojas, Susy
Cox, Chesa
Nakamura, Robert
Petersen, Maya
DeRisi, Joseph
Havlir, Diane V
author_sort Pilarowski, Genay
collection PubMed
description Among 3302 persons tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by BinaxNOW(TM) and reverse transcription polymerase chain reaction (RT-PCR) in a community setting, rapid assay sensitivity was 100%/98.5%/89% using RT-PCR cycle thresholds of 30, 35, and no threshold. The specificity was 99.9%. Performance was high across ages and those with and without symptoms. Rapid resulting permitted immediate public health action.
format Online
Article
Text
id pubmed-7799223
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77992232021-01-25 Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing Pilarowski, Genay Marquez, Carina Rubio, Luis Peng, James Martinez, Jackie Black, Douglas Chamie, Gabriel Jones, Diane Jacobo, Jon Tulier-Laiwa, Valerie Rojas, Susana Rojas, Susy Cox, Chesa Nakamura, Robert Petersen, Maya DeRisi, Joseph Havlir, Diane V Clin Infect Dis Online only Articles Among 3302 persons tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by BinaxNOW(TM) and reverse transcription polymerase chain reaction (RT-PCR) in a community setting, rapid assay sensitivity was 100%/98.5%/89% using RT-PCR cycle thresholds of 30, 35, and no threshold. The specificity was 99.9%. Performance was high across ages and those with and without symptoms. Rapid resulting permitted immediate public health action. Oxford University Press 2020-12-26 /pmc/articles/PMC7799223/ /pubmed/33367619 http://dx.doi.org/10.1093/cid/ciaa1890 Text en © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Online only Articles
Pilarowski, Genay
Marquez, Carina
Rubio, Luis
Peng, James
Martinez, Jackie
Black, Douglas
Chamie, Gabriel
Jones, Diane
Jacobo, Jon
Tulier-Laiwa, Valerie
Rojas, Susana
Rojas, Susy
Cox, Chesa
Nakamura, Robert
Petersen, Maya
DeRisi, Joseph
Havlir, Diane V
Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
title Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
title_full Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
title_fullStr Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
title_full_unstemmed Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
title_short Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
title_sort field performance and public health response using the binaxnow(tm) rapid severe acute respiratory syndrome coronavirus 2 (sars-cov-2) antigen detection assay during community-based testing
topic Online only Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7799223/
https://www.ncbi.nlm.nih.gov/pubmed/33367619
http://dx.doi.org/10.1093/cid/ciaa1890
work_keys_str_mv AT pilarowskigenay fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT marquezcarina fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT rubioluis fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT pengjames fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT martinezjackie fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT blackdouglas fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT chamiegabriel fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT jonesdiane fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT jacobojon fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT tulierlaiwavalerie fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT rojassusana fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT rojassusy fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT coxchesa fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT nakamurarobert fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT petersenmaya fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT derisijoseph fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting
AT havlirdianev fieldperformanceandpublichealthresponseusingthebinaxnowtmrapidsevereacuterespiratorysyndromecoronavirus2sarscov2antigendetectionassayduringcommunitybasedtesting